• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Up 0.19%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqGM
    4.00 Down 0.05(1.23%) Mar 24, 4:00PM EDT
    Prev Close:4.05
    Open:4.05
    Bid:3.95 x 100
    Ask:4.05 x 1000
    1y Target Est:19.42
    Beta:2.73179
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:4.00 - 4.20
    52wk Range:3.80 - 7.94
    Volume:101,626
    Avg Vol (3m):182,666
    Market Cap:128.44M
    P/E (ttm):N/A
    EPS (ttm):-0.76
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVIV

    Comparison

    Symbol% ChgMkt Cap
    NVIVDown 1.23%128.44M
    ALSE 0.00%306.35K
    ACOR 0.00%1.18B
    STEM 0.00%187.31M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-0.80
    Quarterly EPS Est (Mar-17) :-0.22
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback